These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 34744786)

  • 1. Acute Mountain Sickness Following Incremental Trekking to High Altitude: Correlation With Plasma Vascular Endothelial Growth Factor Levels and the Possible Effects of Dexamethasone and Acclimatization Following Re-exposure.
    Winter C; Bjorkman T; Miller S; Nichols P; Cardinal J; O'Rourke P; Ballard E; Nasrallah F; Vegh V
    Front Physiol; 2021; 12():746044. PubMed ID: 34744786
    [No Abstract]   [Full Text] [Related]  

  • 2. Re-exposure to the hypobaric hypoxic brain injury of high altitude: plasma S100B levels and the possible effect of acclimatisation on blood-brain barrier dysfunction.
    Winter CD; Whyte T; Cardinal J; Kenny R; Ballard E
    Neurol Sci; 2016 Apr; 37(4):533-9. PubMed ID: 26924650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum vascular endothelial growth factor is a potential biomarker for acute mountain sickness.
    Nourkami-Tutdibi N; Küllmer J; Dietrich S; Monz D; Zemlin M; Tutdibi E
    Front Physiol; 2023; 14():1083808. PubMed ID: 37064896
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between physiological responses after exercise at low altitude and acute mountain sickness upon ascent is sex-dependent.
    Shen Y; Yang YQ; Liu C; Yang J; Zhang JH; Jin J; Tan H; Yuan FZ; Ke JB; He CY; Zhang LP; Zhang C; Yu J; Huang L
    Mil Med Res; 2020 Nov; 7(1):53. PubMed ID: 33148321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hypoxia related hormones responses in acute mountain sickness susceptibility individuals unaccustomed to high altitude.
    Fayazi B; Tadibi V; Ranjbar K
    PLoS One; 2023; 18(10):e0292173. PubMed ID: 37796960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiorespiratory hysteresis during incremental high-altitude ascent-descent quantifies the magnitude of ventilatory acclimatization.
    Leacy JK; Linares AM; Zouboules SM; Rampuri ZH; Bird JD; Herrington BA; Mann LM; Soriano JE; Thrall SF; Kalker A; Brutsaert TD; O'Halloran KD; Sherpa MT; Day TA
    Exp Physiol; 2021 Jan; 106(1):139-150. PubMed ID: 32421248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness.
    Dorward DA; Thompson AA; Baillie JK; MacDougall M; Hirani N
    Respir Med; 2007 Mar; 101(3):587-94. PubMed ID: 16890420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No correlation between plasma levels of vascular endothelial growth factor or its soluble receptor and acute mountain sickness.
    Schommer K; Wiesegart N; Dehnert C; Mairbäurl H; Bärtsch P
    High Alt Med Biol; 2011; 12(4):323-7. PubMed ID: 22206557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of acute mountain sickness by monitoring arterial oxygen saturation during ascent.
    Karinen HM; Peltonen JE; Kähönen M; Tikkanen HO
    High Alt Med Biol; 2010; 11(4):325-32. PubMed ID: 21190501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Mountain Sickness is Reduced Following 2 Days of Staging During Subsequent Ascent to 4300 m.
    Beidleman BA; Fulco CS; Glickman EL; Cymerman A; Kenefick RW; Cadarette BS; Andrew SP; Staab JE; Sils IV; Muza SR
    High Alt Med Biol; 2018 Dec; 19(4):329-338. PubMed ID: 30517038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neurofilament level increases after ascent to 4559 m but is not related to acute mountain sickness.
    Sareban M; Berger MM; Pinter D; Buchmann A; Macholz F; Schmidt P; Schiefer L; Schimke M; Niebauer J; Steinacker JM; Treff G; Khalil M
    Eur J Neurol; 2021 Mar; 28(3):1004-1008. PubMed ID: 33095952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New metric of hypoxic dose predicts altitude acclimatization status following various ascent profiles.
    Beidleman BA; Fulco CS; Cymerman A; Staab JE; Buller MJ; Muza SR
    Physiol Rep; 2019 Oct; 7(20):e14263. PubMed ID: 31660703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEDEX 2015: Heart Rate Variability Predicts Development of Acute Mountain Sickness.
    Sutherland A; Freer J; Evans L; Dolci A; Crotti M; Macdonald JH
    High Alt Med Biol; 2017 Sep; 18(3):199-208. PubMed ID: 28418725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor and acute mountain sickness.
    Nilles E; Sayward H; D'Onofrio G
    J Emerg Trauma Shock; 2009 Jan; 2(1):6-9. PubMed ID: 19561948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of residence at moderate versus low altitude on reducing acute mountain sickness in men following rapid ascent to 4300 m.
    Staab JE; Beidleman BA; Muza SR; Fulco CS; Rock PB; Cymerman A
    High Alt Med Biol; 2013 Mar; 14(1):13-8. PubMed ID: 23537255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness.
    Tissot van Patot MC; Leadbetter G; Keyes LE; Bendrick-Peart J; Beckey VE; Christians U; Hackett P
    J Appl Physiol (1985); 2005 May; 98(5):1626-9. PubMed ID: 15649874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude.
    Grissom CK; Richer LD; Elstad MR
    Chest; 2005 Feb; 127(2):565-70. PubMed ID: 15705997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residence at Moderate Versus Low Altitude Is Effective at Maintaining Higher Oxygen Saturation During Exercise and Reducing Acute Mountain Sickness Following Fast Ascent to 4559 m.
    Bernardi E; Pomidori L; Cavallari D; Mandolesi G; Cogo A
    Wilderness Environ Med; 2017 Jun; 28(2):122-126. PubMed ID: 28455198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2, IL-17A and TNF-α hold potential as biomarkers for predicting acute mountain sickness prior to ascent.
    Guo H; Wang Q; Li T; Sun W; Chen J; Wang C; Wang C
    Cytokine; 2024 Sep; 181():156694. PubMed ID: 39024679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological responses during ascent to high altitude and the incidence of acute mountain sickness.
    Cobb AB; Levett DZH; Mitchell K; Aveling W; Hurlbut D; Gilbert-Kawai E; Hennis PJ; Mythen MG; Grocott MPW; Martin DS;
    Physiol Rep; 2021 Apr; 9(7):e14809. PubMed ID: 33904650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.